Evidence map›Paper›PMID 37554526›Full record

ArticleTranslational andrology and urology2023

Identification of

Yu Yang, Si Qin, Hongwei Wu, Jiahao Zhang, Qiao Tian, Zhengping Zhao, Benlin Wei, Jorge Hallak, Xiangming Mao

Abstract read
In one paragraph

Article in Translational andrology and urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu Yang *Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Si Qin *Department of Dermatology, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Hongwei Wu *Shenzhen Key Laboratory of Fertility Regulation, Center of Assisted Reproduction and Embryology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Jiahao ZhangDepartment of Urology, Shenzhen Baoan People's Hospital (Group), Shenzhen, China.
Qiao TianDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
Zhengping ZhaoDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
Benlin WeiDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
Jorge HallakAndroscience, Science and Innovation Center in Andrology and High-Complex Clinical and Andrology Research Laboratory, Sao Paulo, Brazil.
Xiangming MaoDepartment of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sertoli cell-only syndrome (SCOS) or germ cell aplasia is one of the most serious histopathological subtypes within the scope of non-obstructive azoospermia (NOA). Understanding the molecular mechanism of SCOS and identifying new non-invasive markers for clinical application is crucial to guide proper sperm procurement and avoid unnecessary interventions. This study sought to identify the differentially expressed genes (DEGs) of SCOS by using gene sequencing identity and verify the key marker genes to provide basic data for subsequent research on SCOS. Methods: A total of 50 testicular samples were collected in this study from 25 patients with SCOS and 25 patients with normal spermatogenesis. In total, 5 pairs of testis samples were used for the RNA-sequencing (RNA-seq). We identified the DEGs between the SCOS and normal spermatogenesis patients and conducted a Gene Ontology (GO) analysis and a Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The expression of the main target gene phosducin-like 2 ( Results: In total, 3,133 upregulated DEGs and 1,406 downregulated DEGs were identified by the RNA-seq. The highly enriched processes involved in spermatogenesis included the mitotic cell cycle, cell cycle, and oocyte maturation. The expression of Conclusions: This study identified the DEGs of SCOS, and the bioinformatics analysis results identified the potential target key genes and pathways for SCOS.

Indexed as

gene sequencingNon-obstructive azoospermia (NOA)phosducin-like 2 (PDCL2)Sertoli cell-only syndrome (SCOS)

Identifiers

PMID37554526
PMCPMC10406544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.